News

Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...
A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating ...
Scientists have developed a tool that can predict how bowel cancer adapts to treatment—helping researchers to design new ...
The actual costs of adverse events were significantly higher than the estimates in cost-effectiveness analyses, with a median difference of $17,201. The costs of adverse events (AEs) from cancer drugs ...
Combining drugs which have different mechanisms of action is an important tool in our arsenal to do this. “For some types of blood cancer, we have shown that combining the targeted drug tazemetostat ...
AI Can Help Patients Get Prostate Cancer Drug That Cuts Death Risk By Half The new AI test, built by a team from the US, UK and Switzerland, shows which men would most likely benefit from abiraterone.
Dr Matthew Hobbs, director of research at Prostate Cancer UK, said: “Prostate Cancer UK has been calling on the UK Government to approve this life-saving, cost-effective drug for over two years.
We compared use of low-value cancer treatments between MA and TM and analyzed variation in use of low-value cancer treatments across large MA insurers. ... Dusetzina SB, Mishra Meza A, et al: ...
Bristol Myers Squibb said Monday it will pay the German firm BioNTech billions of dollars to split rights for an experimental cancer drug called BNT327, which works on both PD-L1, the target of ...
Lung cancer remains the leading cause of cancer mortality worldwide. Immunotherapy has recently emerged as a promising therapeutic strategy both for ...